An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users

NCT00841477 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1260

Enrollment

NIH

Sponsor class

Conditions

Hepatitis B Infection
Hepatitis C Infection
HIV Infection

Interventions

BIOLOGICAL: hepatitis B vaccine 3 dose schedule (0,1,2 month)
BEHAVIORAL: HBV Vaccination Self-Efficacy Intervention

Sponsor

National Institute on Drug Abuse (NIDA)